IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study (MASS)
This study is currently recruiting participants.
Verified January 2017 by Michio Hirano, Columbia University
Sponsor:
Michio Hirano
Collaborators:
Cornell University
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
Michio Hirano, Columbia University
ClinicalTrials.gov Identifier:
NCT02427178
First received: February 10, 2015
Last updated: January 25, 2017
Last verified: January 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2023 |
| Estimated Primary Completion Date: | June 2022 (Final data collection date for primary outcome measure) |